MedPath

Effect of vonoprazan, a potassium competitive acid blocker, in post endoscopic submucosal dissection ulcer healing

Not Applicable
Conditions
early gastric cancer/gastric adenoma
Registration Number
JPRN-UMIN000022595
Lead Sponsor
agasaki University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
115
Inclusion Criteria

Not provided

Exclusion Criteria

1) The patients on antithrombotic therapy. 2) The patients on dialysis. 3) The patients with a history of allergy to vonoprazan. 4) The patients on administration of atazanavir or rilpivirine. 5) Those who are considered to be inappropriate for this study by doctors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath